American International Group’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-2,424
| Closed | -$37.5K | – | 1585 |
|
2024
Q1 | $37.5K | Buy |
2,424
+6
| +0.2% | +$93 | ﹤0.01% | 2842 |
|
2023
Q4 | $67.7K | Sell |
2,418
-9
| -0.4% | -$252 | ﹤0.01% | 2735 |
|
2023
Q3 | $116K | Buy |
2,427
+86
| +4% | +$4.09K | ﹤0.01% | 2429 |
|
2023
Q2 | $224K | Buy |
2,341
+641
| +38% | +$61.4K | ﹤0.01% | 2096 |
|
2023
Q1 | $193K | Buy |
1,700
+33
| +2% | +$3.74K | ﹤0.01% | 2126 |
|
2022
Q4 | $187K | Sell |
1,667
-6
| -0.4% | -$672 | ﹤0.01% | 2163 |
|
2022
Q3 | $215K | Buy |
1,673
+24
| +1% | +$3.08K | ﹤0.01% | 2114 |
|
2022
Q2 | $113K | Sell |
1,649
-79
| -5% | -$5.41K | ﹤0.01% | 2529 |
|
2022
Q1 | $246K | Sell |
1,728
-121
| -7% | -$17.2K | ﹤0.01% | 2116 |
|
2021
Q4 | $308K | Sell |
1,849
-56
| -3% | -$9.33K | ﹤0.01% | 2099 |
|
2021
Q3 | $265K | Sell |
1,905
-45
| -2% | -$6.26K | ﹤0.01% | 2255 |
|
2021
Q2 | $930 | Buy |
1,950
+340
| +21% | +$162 | ﹤0.01% | 1558 |
|
2021
Q1 | $663 | Buy |
1,610
+5
| +0.3% | +$2 | ﹤0.01% | 1687 |
|
2020
Q4 | $787 | Buy |
1,605
+18
| +1% | +$9 | ﹤0.01% | 1522 |
|
2020
Q3 | $899K | Buy |
1,587
+243
| +18% | +$138K | ﹤0.01% | 1306 |
|
2020
Q2 | $128K | Buy |
1,344
+264
| +24% | +$25.1K | ﹤0.01% | 2371 |
|
2020
Q1 | $77K | Sell |
1,080
-62
| -5% | -$4.42K | ﹤0.01% | 2467 |
|
2019
Q4 | $79K | Sell |
1,142
-10
| -0.9% | -$692 | ﹤0.01% | 2738 |
|
2019
Q3 | $92K | Buy |
1,152
+470
| +69% | +$37.5K | ﹤0.01% | 2659 |
|
2019
Q2 | $44K | Buy |
682
+25
| +4% | +$1.61K | ﹤0.01% | 2972 |
|
2019
Q1 | $90K | Sell |
657
-21
| -3% | -$2.88K | ﹤0.01% | 2668 |
|
2018
Q4 | $61K | Sell |
678
-5
| -0.7% | -$450 | ﹤0.01% | 2816 |
|
2018
Q3 | $104K | Buy |
683
+12
| +2% | +$1.83K | ﹤0.01% | 2818 |
|
2018
Q2 | $115K | Buy |
671
+17
| +3% | +$2.91K | ﹤0.01% | 2703 |
|
2018
Q1 | $96K | Sell |
654
-35
| -5% | -$5.14K | ﹤0.01% | 2675 |
|
2017
Q4 | $140K | Buy |
689
+3
| +0.4% | +$610 | ﹤0.01% | 2539 |
|
2017
Q3 | $220K | Buy |
686
+52
| +8% | +$16.7K | ﹤0.01% | 2243 |
|
2017
Q2 | $143K | Buy |
634
+85
| +15% | +$19.2K | ﹤0.01% | 2486 |
|
2017
Q1 | $124K | Buy |
549
+36
| +7% | +$8.13K | ﹤0.01% | 2470 |
|
2016
Q4 | $101K | Sell |
513
-1
| -0.2% | -$197 | ﹤0.01% | 2601 |
|
2016
Q3 | $126K | Buy |
514
+1
| +0.2% | +$246 | ﹤0.01% | 2468 |
|
2016
Q2 | $298K | Buy |
513
+264
| +106% | +$153K | ﹤0.01% | 1880 |
|
2016
Q1 | $132K | Buy |
+249
| New | +$132K | ﹤0.01% | 3164 |
|